appetite-suppressing glp-1 treatments Medications: Is Ozempic the Best Option for You? How Long Does It Take

Pushing the Boundaries of GLP-1 Innovation Hanmi to Present Six Obesity Drug Studies at ADA 2025Hanmi Pharmaceutical to Unveil Six Research Updates on HM15275 and HM17321 at ADA 2025Phase 1 Results of Next-Generation Triple Agonist HM15275 to Be Unveiled for the First Time

This isn't a pharma story

GLP-1 receptor agonists (like Ozempic, Wegovy, Mounjaro, and Zepbound) have exploded in popularity for their powerful effects on appetite suppression, blood sugar regulation, and weight loss support

Feel lighter, more energized, and in control of your gut health every day

As we await prospective data, clinical practice should consider the difference between abrupt stop vs gradual taper when counseling patients about expectations after therapy

Clinician-written guides on GLP-1s, phentermine, metabolism, safe weight loss, and progress tracking